Jeffrey Del Carmen Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

Jeffrey Del Carmen is Chief Commercial Officer of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 14,337 shares of CPRX, which is worth approximately $332,331. The most recent transaction as insider was on Dec 29, 2025, when has been sold 3,839 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.3K

Infinity% 3M change

37.34% 12M change

Total Value Held $332,331

Jeffrey Del Carmen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 29 2025	SELL Payment of exercise price or tax liability	-	3,839 Reduced 21.12%	14,337 Common Stock, par valu...
Dec 29 2025	BUY Exercise of conversion of derivative security	-	8,667 Added 32.29%	18,176 Common Stock, par valu...
Dec 08 2025	SELL Payment of exercise price or tax liability	-	2,492 Reduced 20.76%	9,509 Common Stock, par valu...
Dec 08 2025	BUY Exercise of conversion of derivative security	-	8,039 Added 40.11%	12,001 Common Stock, par valu...
Nov 26 2025	SELL Open market or private sale	$256,233 $23.33 p/Share	10,983 Reduced 73.49%	3,962 Common Stock, par valu...
Nov 26 2025	BUY Exercise of conversion of derivative security	$46,238 $4.21 p/Share	10,983 Added 42.36%	14,945 Common Stock, par valu...
Nov 21 2025	SELL Payment of exercise price or tax liability	-	1,641 Reduced 29.29%	3,962 Common Stock, par valu...

Nov 21 2025	BUY Exercise of conversion of derivative security	-	5,603 Added 50.0%	5,603 Common Stock, par valu...
Mar 03 2025	SELL Open market or private sale	$696,382 $22.89 p/Share	30,423 Reduced 100.0%	0 Common Stock, par valu...
Feb 14 2025	SELL Payment of exercise price or tax liability	-	3,125 Reduced 9.32%	30,423 Common Stock, par valu...
Feb 14 2025	BUY Exercise of conversion of derivative security	-	10,667 Added 24.13%	33,548 Common Stock, par valu...
Dec 27 2024	SELL Payment of exercise price or tax liability	-	3,839 Reduced 14.37%	22,881 Common Stock, par valu...
Dec 27 2024	BUY Exercise of conversion of derivative security	-	8,667 Added 24.49%	26,720 Common Stock, par valu...
Dec 09 2024	SELL Payment of exercise price or tax liability	-	2,355 Reduced 11.54%	18,053 Common Stock, par valu...
Dec 09 2024	BUY Exercise of conversion of derivative security	-	8,039 Added 28.26%	20,408 Common Stock, par valu...
Aug 09 2024	SELL Open market or private sale	$664,548 $18.43 p/Share	36,058 Reduced 74.46%	12,369 Common Stock, par valu...
Aug 09 2024	BUY Exercise of conversion of derivative security	$85,800 $2.86 p/Share	30,000 Added 41.45%	42,369 Common Stock, par valu...
Jun 07 2024	SELL Open market or private sale	$121,183 $16.07 p/Share	7,541 Reduced 29.04%	18,427 Common Stock, par valu...
Feb 15 2024	SELL Payment of exercise price or tax liability	-	3,125 Reduced 10.74%	25,968 Common Stock, par valu...
Feb 15 2024	BUY Exercise of conversion of derivative security	-	10,667 Added 26.83%	29,093 Common Stock, par valu...
Dec 27 2023	SELL Payment of exercise price or tax liability	-	3,839 Reduced 17.24%	18,426 Common Stock, par valu...
Dec 27 2023	BUY Exercise of conversion of derivative security	-	8,666 Added 28.02%	22,265 Common Stock, par valu...
Jun 27 2023	SELL Payment of exercise price or tax liability	-	3,942 Reduced 22.47%	13,599 Common Stock, par valu...
Jun 27 2023	BUY Exercise of conversion of derivative security	-	10,000 Added 36.31%	17,541 Common Stock, par valu...
Mar 29 2023	SELL Open market or private sale	$668,000 $16.7 p/Share	40,000 Reduced 84.14%	7,541 Common Stock, par valu...

JDC

Jeffrey Del Carmen

Chief Commercial Officer

Coral Gables, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX

Account